Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Phase 3
Completed
- Conditions
- Borderline Personality Disorder
- Interventions
- Drug: Placebo (for Selegiline)
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Mood and Anxiety Research, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT01912391
- Locations
- 🇺🇸
Mood and Anxiety Research, Inc, Fresno, California, United States
© Copyright 2025. All Rights Reserved by MedPath